Sunesis to Present at Upcoming Investor Conferences
SOUTH SAN FRANCISCO, CA, Jun 03, 2010 (MARKETWIRE via COMTEX News Network) -- Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS), a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers, today announced that Daniel Swisher, Chief Executive Officer of Sunesis, will present at three upcoming conferences:
-- 9th Annual Needham Healthcare Conference Wednesday, June 9 at 10:40 a.m. EDT New York Palace Hotel, New York City -- Jefferies 2010 Global Life Sciences Conference Thursday, June 10 at 8:00 a.m. EDT Grand Hyatt, New York City -- ThinkEquity Mid Year Check-Up on Healthcare Wednesday, June 16 at 11:30 a.m. EDT The Princeton Club, New York City
Alive webcast of the Jefferies presentation on June 10th will be available on the Sunesis website at http://ir.sunesis.com. A replay of that webcast will be archived on the "Calendar of Events" page in the Investors and Media section of the Sunesis website for two weeks following the presentation.
About Sunesis Pharmaceuticals
Sunesis is a biopharmaceutical company focused on the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Sunesis has built a highly experienced cancer drug development organization committed to advancing its lead product candidate, voreloxin, in multiple indications to improve the lives of people with cancer. For additional information on Sunesis, please visit http://www.sunesis.com.
SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.
Investor and Media Inquiries: Andrea Rabney Argot Partners 212-600-1902 Eric Bjerkholt Sunesis Pharmaceuticals Inc. 650-266-3717
SOURCE: Sunesis Pharmaceuticals, Inc.
Copyright 2010 Marketwire, Inc., All rights reserved.
News Provided by COMTEX